Introduction
The NF-kB/Rel proteins correspond to a family of ubiquitous and often inducible transcription factors that regulate an array of target genes involved in the immune, in¯ammatory, anti-apoptotic, and acutephase responses (Baeuerle and Baltimore, 1996; Baeuerle and Henkel, 1994; Baldwin, 1996; Barnes and Karin, 1997; Gilmore et al., 1996; Siebenlist et al., 1994) . These NF-kB/Rel family members share a 300-amino acid, N-terminal Rel homology domain (RHD) that mediates DNA binding and subunit dimerization, but dierent Rel complexes preferentially bind to dierent enhancer elements located within the target genes (Baeuerle and Baltimore, 1996; Baeuerle and Henkel, 1994; Baldwin, 1996; Gilmore et al., 1996; Siebenlist et al., 1994) . In most cell types, NF-kB/Rel transcription factors are sequestered in the cytoplasm of unstimulated cells by their assembly with a set of inhibitory proteins, termed IkBs. Nuclear expression of NF-kB is activated by a wide range of stimuli, including proin¯ammatory cytokines, phorbol ester, lipopolysaccharide, viral infection, and conditions leading to intracellular oxidation (Baeuerle and Baltimore, 1996; Baeuerle and Henkel, 1994; Baldwin, 1996; Barnes and Karin, 1997; Gilmore et al., 1996; Siebenlist et al., 1994) . While the major induced form of NF-kB corresponds to a heterodimer composed of p65 (RelA) and p50 (nfkb1), other family members, including p52 (nfkb2), also participate in the formation of Rel-related transcription factor complexes. Dimers of p52-c-Rel and p52-RelB appear to play a particularly important role in the terminal stages of B-cell dierentiation (Grumont and Gerondakis, 1994; Liou et al., 1994) . Although expressed at low levels in many cells (Betts and Nabel, 1996) , p52 is characteristically expressed at higher levels in dendritic cells, T cells, and macrophages (Baeuerle and Baltimore, 1996; Baeuerle and Henkel, 1994; Baldwin, 1996; Barnes and Karin, 1997; Feuillard et al., 1996; Gilmore et al., 1996; Grumont and Gerondakis, 1994; Liou et al., 1994; Siebenlist et al., 1994) .
Unique among the Rel family members, the nfkb1 and nfkb2 genes each encode two proteins: p105/p50 and p100/p52, respectively (Bours et al., 1992; Ghosh et al., 1990; Kieran et al., 1990; Schmid et al., 1991) . The p105 and p100 proteins exhibit IkB properties due to a cluster of ankyrin repeats (Baldwin, 1996) in their C-terminal domains. In contrast, p52 and p50, which represent approximately the N-terminal halves of p100 and p105, respectively, lack these ankyrin repeats and function as Rel-related transcription factors.
nfkb2 was ®rst detected as a rearranged gene in certain B-cell lymphomas (Neri et al., 1991) . Truncations in the C-terminal region of the nfkb2 gene are also associated with the development of various hematopoietic tumors, including chronic lymphocytic leukemia, multiple myeloma, and cutaneous T-cell lymphoma (Neri et al., 1991 (Neri et al., , 1996 . Studies by Zhang et al. (1994) have shown that many of these nfkb2 rearrangements result in the synthesis of abnormal proteins that are constitutively expressed in the nucleus and lack IkB-like properties. The p52 protein also associates with the IkB-like Bcl-3 oncoprotein, leading to the formation of a functional transcription factor complex (Bours et al., 1993) .
Additional insights into the biology of p52 and p100 have stemmed from disruption of the germline nfkb2 gene (Caamano et al., 1998; Franzoso et al., 1998) . Knockout mice lacking both p52 and p100 production display a marked reduction of cells in the Blymphocyte compartment, altered splenic microarchitecture, defects in secondary germinal center formation, decreased B-cell proliferation in the presence of lipopolysaccharide, anti-IgD, dextran and CD40 ligation, blunted humoral responses to T cell-dependent and -independent antigens, and an absence of a follicular dendritic cell network within secondary lymphoid organs. Taken together, these ®ndings emphasize a central role for the nfkb2 gene in the maintenance of the peripheral B-cell population, humoral immune responsiveness, and splenic architecture.
Further highlighting the distinct functions of the two nfkb2 gene products, selective disruption of p100 expression in the presence of normal p52 production (termination codon introduced at codon 451) results in a very dierent constellation of ®ndings, including marked gastric hyperplasia associated with early postnatal death, lymph node enlargement, increased lymphocyte proliferation in response to several stimuli, and enhanced cytokine production by activated T cells. These animals also display a signi®cant increase in nuclear kB-speci®c DNA binding activity containing p52. This latter ®nding suggests that p100 plays an important role in the regulation of p52-containing NF-kB/Rel complexes and, further, that this activity is not eciently replaced by other IkB proteins (Ishikawa et al., 1997) . The nfkb1 gene product undergoes cotranslational processing mediated by the proteasome, yielding p50 (Lin et al., 1998) . Because nfkb2 shares signi®cant homology with nfkb1, p52 may be generated in a similar fashion. We performed a series of studies aimed at dissecting the molecular basis for p100 and p52 production. We ®nd that p52 biogenesis, like that of p50, principally occurs in a cotranslational manner involving proteolytic processing by the proteasome. However, we also ®nd that the processing of p100 is much less ecient than that of p105. While this processing is dependent on the GRR located downstream of the RHD of p52, the diminished processing Figure 1 Pulse-chase radiolabeling analysis of p52 generation in vivo. (a) CHO-CD14 cells were transfected with a human p100 expression vector. The next day, the cells were pulse radiolabeled with 35 S-methionine/cysteine for 30, 45, or 60 min and chased for 1 h. The lysates were immunoprecipitated with a rabbit polyclonal antiserum speci®c for the p100/p52 N-terminus. Lanes 1 ± 3 correspond to varying times of pulse, while lane 4 represents harvest after 1 h of chase; lane 5 represents the immunoprecipitate from cells transfected with empty vector at the 1-h chase timepoint. (b) CHO-CD14 cells were harvested and lysed after pulse radiolabeling for 2 h (0 h of chase) and after 2, 5, 8 and 12 h of chase. Timepoints are indicated for lanes 1 ± 6. Both p100 and p52 are indicated, as well as a nonspeci®c (n.s.) band Figure 2 Analysis of p52 and p100 production in synchronized in vitro translations. Linearized mRNA encoding full-length p100 was used to program rabbit reticulocyte lysates. Three minutes after initiation of translation, aurintricarboxylic acid was added to block further ribosome initiation. Production of p52 and p100 was then monitored in the synchronized translation mixture. Production of p52 was ®rst detected at 7.5 min (lane 2), while p100 was not detected until 15 min (lane 5). Lane 8 depicts results obtained after 45 min of unsynchronized translation of p52 relative to the nfkb1-derived p50 product re¯ects properties conferred by peptide sequences anking the site of proteasome processing, positioned downstream of the GRR.
Results
p52 and p100 do not display a classical precursorproduct relationship To investigate the relationship between p100 and p52, we performed in vivo pulse-chase radiolabeling studies in CHO-CD14 cells transfected with human p100 expression vector DNA (Figure 1 ). Radiolabeling of both the p52 and p100 species in these cells was detected at all timepoints (30 min, 45 min, and 1 h during the pulse-labeling phase of the experiment (Figure 1a ). Subsequent chase for 1 ± 12 h did not reveal signi®cant migration of radiolabel from p100 to p52 (Figure 1a and b) . At the 12-h timepoint during the chase, the intensity of both the p100 and p52 proteins declined in parallel, suggesting that these proteins were degraded. Densitometric quantitation of the bands corresponding to p100 and p52 at the various timepoints revealed that the rate of increase of p52 radiolabeling during the pulse labeling period was &100-fold higher than the rate of p52 radiolabeling during the ®rst few hours of the chase (data not shown). These results indicate that p100 and p52 do not share a classical precursor-product relationship. Rather, the early radiolabeling of both proteins raises the possibility that p52 production may be closely linked with the translation of nfkb2 mRNA. nfkb2 p52 is produced before completion of full-length nfkb2 p100 synthesis
We next performed synchronized in vitro translation experiments employing aurintricarboxylic acid to block ribosome initiation but not elongation (Figure 2 ). In such synchronized translations, p52 production was detected after 7.5 min of translation at 308C. In contrast, p100 production was not detected before Figure 3 Construction and analysis of processing of C-terminal truncation mutants of the nfkb2 gene. (a) Schematic overview of p100 structure and the series of nested C-terminal truncation mutants. NLS, nuclear localization sequence. The number associated with each truncation mutant re¯ects the C-terminal amino acid of the translated protein. All mutants were inserted in the pcDNA 3.1 vector, which permits eukaryotic expression using a CMV-based promoter or production of mRNA for in vitro transcription/ translation using T7 polymerase. (b) Evaluation of p52 generation with the nfkb2 C-terminal truncation in vivo. Expression vectors encoding C-terminal truncation mutants ending at residues 484, 454, 439, 424, and 409 or p100 were expressed in CHO-CD14 cells. Lysates were prepared 24 ± 48 h later and immunoblotted with an antiserum that speci®cally reacts with the shared N-terminus of p100/p52. Lane 1 shows the immunoblotting results obtained with cells transfected with wild-type p100; lanes 2 ± 6 depict results obtained with indicated mutants of p100, while lane 7 corresponds to lysate from cells transfected with empty vector DNA. (c) Evaluation of p52 generation by the nfkb2 C-terminal truncation mutants in vitro. The same mutants shown in (a) were linearized with XbaI to include a translation termination codon and then used as templates for in vitro transcription and translation. Lane 1 shows results obtained with wild-type nfkb2 gene product. Lanes 2 ± 4 show results for the C-terminal deletion mutants ending at amino acids 484, 454, and 439, respectively, while lane 5 shows the immunoprecipitate from translations performed with linearized vector DNA lacking an insert. (d) p52 generation in vitro with p100 deletion mutants lacking a stop codon. The p100 C-terminal truncation expression vectors were linearized with EcoRI, which excluded the translation termination codon, and then utilized as templates for in vitro transcription and translation in rabbit reticulocyte lysates. The lysates were then immunoprecipitated with antiserum speci®c for the N-terminus of p100/p52. Lanes 1 ± 4 show the immunoprecipitation results obtained for full-length p100 and the p100 deletion mutants terminating at amino acids 484, 454, and 439, respectively; lane 5 shows results for lysate programmed with mRNA from the empty linearized vector 15 min of translation at this temperature. These results demonstrate that full-length p100 is not required to generate p52.
Translation of the ®rst 454 amino acids of the nfkb2 gene product suces for the generation of nfkb2 p52
Since the pulse-chase radiolabeling studies suggested that synthesis of the full-length p100 protein was not required for production of p52, we analysed how much of the nfkb2 coding region was required for p52 production. Stop codons were introduced at amino acid 409 and at 15-to 30-amino acid intervals (424, 439, 454, and 484) (Figure 3a) . Of note, the C-terminus of p52 is located at or around amino acid 405 (Betts and Nabel, 1996) . When CHO-CD14 cells were transfected with this series of nested C-terminal truncation mutants, p52 generation was readily detected with the 1 ± 484 and 1 ± 454 constructs ( Figure 3b, lanes 2 and 3) . In contrast, the shorter 1 ± 439, 1 ± 424, and 1 ± 409 constructs did not support p52 production (Figure 3b , lanes 4 ± 6).
These same C-terminal p100 deletion mutants were next analysed in vitro using mRNA generated from each to program translation in rabbit reticulocyte lysates (Figure 3c ). While p52 generation was, overall, less ecient in vitro, p52 was similarly generated from the 1 ± 484 and 1 ± 454 constructs but not the 1 ± 439 construct ( Figure 3c , lanes 2 ± 4). These ®ndings indicate that the full-length p100 protein is not required for p52 production either in vivo or in vitro.
These in vitro transcription vectors were also engineered to contain a 3' restriction site permitting the generation of mRNAs lacking a translation termination codon. In the absence of a stop codon, the translating ribosomes stall at the end of the Table 1 Comparison of GRRs of the human and mouse p105 and p100
Alignment of sequences spanning the GRR of human p105, murine p105, and human p100. The glycine residues have been shaded and a dot indicates amino acid identity with human p105. Sequences¯anking the N-and C-termini of the GRR have been included for comparison Figure 4 The generation of p52 is blocked by proteasome inhibitors and is dependent on the GRR segment, and the site of processing is altered by repositioning of the GRR. (a) CHO-CD14 cells were transfected with a human p100 expression vector and cultured overnight at 378C. The cells were then treated with either clasto-lactacystin-b lactone or MG115 dissolved in dimethylsulfoxide for 1 h before labeling with 35 S-methionine/cysteine for a 1-h pulse period. After a 1-h period of chase, the cells were harvested, lysed, and immunoprecipitated with a rabbit polyclonal antiserum speci®c for the N-terminus of p100/p52. Immunoprecipitates from transfected cells exposed to dimethylsulfoxide (DMSO) alone (lane 1), clasto-lactacystin b-lactone (10 mM) (lane 2), MG115 either (10 mM) (lane 3), or untreated transfected cells (lane 4) were analysed by SDS ± PAGE. (b) CHO-CD14 cells were transfected with either the wild-type p100 or the DGRR deletion mutant, which lacks the coding region for amino acids 346 ± 377. This deletion spans the putative GRR (see Table 1 ). The cells were lysed 24 ± 48 h later and immunoblotted with rabbit polyclonal antiserum speci®c for the N-terminus of p100/p52. Lane 1 shows lysate from cells transfected with the wild-type p100 expression vector; lane 2 shows lysate from cells transfected with the p100/DGRR vector; lane 3 shows lysate from a control transfection with empty expression vector. (c) CHO-CD14 cells were transfected with wild-type p100 or a p100 GRR translocation mutant (p100/DGRR : GRR(292 ± 323)), where the GRR was moved from its normal position between amino acids 346 and 377 to an upstream position between amino acids 292 and 323. The cells were lysed 24 ± 48 h later and subjected to immunoblotting using a rabbit polyclonal antiserum speci®c for the N-terminus of p100/p52. Lane 1 shows lysate from cells transfected with the wild-type p100 expression vector; lane 2 shows lysate from cells transfected with p100/DGRR : GRR(292 ± 323); lane 3 shows immunoblotting results from cells transfected with empty expression vector DNA. P52' indicates the smaller species generated from the GRR translocation mutant mRNA, and the newly synthesized protein remains tethered as a peptidyl tRNA (Crowley et al., 1993; Frydman et al., 1994) . Analysis of p52 production from such products generated in vitro and lacking a stop codon revealed that p52 was generated not only with the 1 ± 484 and 1 ± 454 constructs, but also with the 1 ± 439 constructs ( Figure 3d, lanes 2 ± 4) . The low level of p52 generation observed with the 1 ± 439 construct was consistently observed in multiple experiments. Of note, this 1 ± 439 construct was not processed to p52 in vivo (Figure 3b, lane 4) or in vitro in the presence of a stop codon (Figure 3c, lane 4) . These ®ndings indicate that in vitro, a 439-amino acid nfkb2 polypeptide suces for p52 production when it is a peptidyl-tRNA.
The generation of p52 is blocked by inhibitors of the proteasome and depends on the GRR
We next examined whether the proteasome is required for p52 production. Previous studies by Betts and Nabel (1996) have shown that the generation of p52 is signi®cantly inhibited by treatment of cells with the peptide aldehyde inhibitors PSI and MG132, which target dierent enzymatic activities within the multicatalytic proteinase complex (proteasome). In our current study, p52 generation was inhibited by the peptide aldehyde inhibitor MG115 (Figure 4a, lane 3) and by the more speci®c proteasome inhibitor, clastolactacystin b-lactone (an active metabolite of lactacystin) (Figure 4a , lane 2), as compared with the DMSO diluent control. In contrast, these compounds exerted no apparent inhibitory eects on the production of p100. These data, including those obtained with the highly speci®c lactacystin derivative, suggest that the proteasome plays a central role in the cotranslational processing reaction leading to p52 generation.
We next examined whether the nfkb2 GRR is required for the generation of p52. Of note, the GRR present in human p100/p52 displays signi®cant sequence homology with the murine p105/p50 GRR, which has been shown to be essential for p50 generation (Lin and Ghosh, 1996) (Table 1) . Immunoblotting of lysates from CHO-CD14 cells transfected with the p100/DGRR mutant lacking amino acids 346 ± 377 revealed a lack of p52 generation but continued production of the full-length p100 protein (Figure 4b ). These ®ndings suggest that the p100 GRR is required for the generation of p52.
To further assess the function of the GRR in p52 generation, we repositioned this element at a site 180 base pairs upstream from its normal location. Immunoblotting of lysates from CHO-CD14 cells transfected with this GRR translocation mutant revealed the production of a predictably smaller protein (Figure 4c, lane 2) . These results suggest that the GRR plays an important role in determining the site of proteasome-mediated processing and, thus, the C-terminus of the resultant product. nfkb2 p52 is generated less eciently than nfkb1 p50 in vivo A survey of several cell types suggests that levels of p52 are often signi®cantly lower than levels of p50. To explore the biological basis for this phenomenon, we assessed the eciency of p52 and p50 generation in CHO-CD14 cells transfected with p100/p52 and p105/ p50 expression vectors ( Figure 5 ). Using antisera speci®c for the amino termini of the nfkb2 and nfkb1 gene products, we observed that signi®cantly less p52 was generated relative to the level of p100 than of p50 relative to p105. Quantitative densitometry revealed a p52 : p100 ratio of 0.07, while the p50 : p105 ratio was 0.81. Similar results were obtained in six additional experiments. Overall, p50 production was 11 ± 12 times more ecient than that observed for p50 in these transfected CHO-CD14 cells.
Sequences downstream of the p100 GRR signi®cantly contribute to the lower eciency of p52 production To dissect the molecular basis for the lower eciency of p52 generation, we prepared chimeric proteins in which the GRR and/or downstream sequence elements were exchanged with their counterparts in the nfkb1 and nfkb2 gene products (Figure 6a ). These chimeric proteins are designated by numerical combinations of 1 or 2, according to whether the protein segment is derived from the nfkb1 or nfkb2 gene. When transfected into CHO-CD14 cells, the 2-1-1 construct (p100 NH 2 ± p105 GRR ± p105 COOH) displayed a signi®cant augmentation in p52 generation compared with wild-type p100 (2-2-2) (Figure 6b, lanes 1 ± 2) . These ®ndings suggested that either the p105-derived GRR or downstream sequences, or both, enhanced processing. To dissect the contribution of these two elements, we analysed processing of the 2-2-1 chimera (p100 NH 2 ± p100 GRR ± p105 COOH) (Figure 6b , lane 3). This chimera was processed at an even higher level than the 2-1-1 construct, indicating that the nfkb2 GRR is not the cause of the less ecient processing. Rather, the downstream sequences of the nfkb1 gene appear sucient to signi®cantly reverse the ineciency of nfkb2 p52 generation.
Next, we investigated whether p50 generation was conversely aected by insertion of the p100 GRR or downstream sequences. Chimeric proteins were synthe- Figure 5 Steady-state analysis of p52 and p50 production in vivo. CHO-CD14 cells were transfected with human p100 or p105 expression vectors. The cell lysates were harvested 48 h later and subjected to immunoblotting analysis with rabbit polyclonal antisera speci®c for the shared N-terminus of the p100/p52 protein or of the p105/p50 protein. Densitometric analysis of the resulting bands was performed to quantitate the ratios of p52 : p100 and p50 : p105 produced sized containing the N-terminal p105/p50 sequence (extending to or through the GRR) linked to the Cterminus of p100 (from the beginning or end of the GRR) (Figure 6a ). After transfection of these expression vectors, p50 generation was assessed. The 1-2-2 construct (p105 NH 2 ± p100 GRR ± p100 COOH) produced sharply diminished levels of p50 relative to wild-type p105 (1-1-1) , a ®nding reminiscent of the less ecient processing of p52. This decrease in p50 generation mapped to the p100 downstream sequence and not the nfkb2 GRR, since the 1-1-2 construct (p105 NH 2 ± p105 GRR ± p100 COOH) also yielded very small quantities of p50. Together, these data argue that sequences located downstream of the GRR of the nfkb1 and nfkb2 genes, and not the GRR, play a dominant role in determining the diering degrees of cotranslational processing eciency observed for p50 and p52.
Discussion
In this study, we demonstrate that the nfkb2 gene product, p52, is principally generated by a cotranslational proteolytic processing reaction involving the proteasome. This processing of nfkb2 p52 closely resembles the proteasome-dependent cotranslational processing ®rst observed with nfkb1 p50 (Lin et al., 1998) . The cotranslational nature of this processing reaction is supported by the ability of a peptidyl-tRNA Figure 6 Evaluation of processing in p100/p105 chimera. (a) Schematic depiction of p100/p105 chimeric constructs. 2-2-2 corresponds to the wild-type nfkb2-derived p100 protein, while 2-1-1 consists of NH 2 p100, nfkb1 105-derived GRR, and COOH sequences from nfkb1 p105. The organization of the other various chimeras is shown. (b) Steady-state analysis of p52 generation in vivo obtained with the various p100/p105 chimeras. CHO-CD14 cells were transfected with wild-type p100 (2-2-2), 2-1-1, or 2-2-1 chimeric expression vectors as indicated. The transfected cells were harvested 48 h later, and lysates were prepared and immunoblotted with a rabbit polyclonal antiserum speci®c for the N-terminus of p100/p52. Lane 1 shows results obtained with wildtype p100 (2-2-2), while lanes 2 and 3 show the results obtained with the 2-1-1 and 2-2-1 chimeras, respectively; lane 4 shows results for the lysates of cells transfected with empty expression vector. (c) Steady-state analysis of p50 generation in vivo from p105/p100 chimeras, CHO-CD14 cells were transfected with wild-type p105 (1-1-1), 1-2-2, or 1-1-2 chimeric expression vectors as indicated. The cells were harvested as described above and immunoblotted with a rabbit polyclonal antiserum speci®c for the N-terminus of p105/p50 to generate p52 in vitro and by the synchronized in vitro translational experiments, where p52 is produced before the synthesis of full-length p100. This unique cotranslational processing observed with both the nfkb2 and nfkb1 genes represents a novel strategy that ensures the independent functions of p52/p50 as NF-kB/Rel transcription factors (Bours et al., 1992; Duckett et al., 1993; Schmid et al., 1991) and of p100/ p105 as selective IkB-like inhibitors of NF-kB (Mercurio et al., 1993; Rice et al., 1992) .
Our in vitro and in vivo studies suggest that the two nfkb2-encoded proteins, p100 and p52, do not exhibit a classical precursor-product relationship. Indeed, p52 and p100 were both radiolabeled at the earliest timepoint examined (30 min). In the synchronized in vitro translation experiments, p52 production was observed before the completion of p100 synthesis. Additionally, the analysis of a series of nested Cterminal truncation mutants of the nfkb2 gene indicated that sequences located downstream of amino acid 454 were dispensable for p52 production in vivo. These ®ndings are in agreement with the earlier work of Betts and Nabel (1996) , who reported that Cterminal sequences of p100 could be replaced with foreign sequences without compromising p52 production, and with ®ndings obtained in the p100 knockout mice, where p52 production was retained after introduction of a stop codon at position 451.
The 26S proteasome corresponds to a high molecular weight multicatalytic protease complex that is responsible for most nonlysosomal intracellular protein degradation (Baumeister et al., 1998) . Our studies now demonstrate that two dierent types of proteasome inhibitors, MG115 and clasto-lactacystin b-lactone, inhibit p52 generation. These results con®rm and extend the ®ndings of Betts and Nabel (1996) , who have similarly suggested the involvement of the proteasome in p52 generation. The p52 product of the nfkb2 gene thus joins nfkb1 p50 as the second example of a cellular protein that is processed, rather than completely degraded, by the proteasome.
What shared features of the nfkb1 and nfkb2 gene products are involved in this proteasome-mediated processing? Both of these proteins contain a GRR. Prior studies have shown that the nfkb1 GRR is essential for p50 generation (Lin and Ghosh, 1996) . Our studies now demonstrate that the related GRR of the nfkb2 gene product is similarly required for p52 generation. Translocation of the GRR to a new site 60 amino acids upstream of its normal location results in the generation of a smaller protein that likely ends at or around residue 345 rather than at residue 405. This result suggests that the GRR may play an important role in determining the site of proteasome processing and, thus, the C-terminus of p52.
Compared with the p50 : p105 ratio, the p52 : p100 ratio is quite small (11 ± 12-fold less) in CHO-CD14 cells. This recapitulates the situation observed in many cells. Through the construction of p100/p105 protein chimeras, we have dissected the molecular basis for the diminished eciency of p52 processing. The substitution of sequences located downstream of the p100 GRR for those present in p105 signi®cantly decreased processing by 87%. Substituting the nfkb2 GRR into the nfkb1 gene did not further inhibit processing; indeed, a slight increase in p50 production was obtained. Conversely, when the downstream region of p105 was inserted into p100, p52 generation increased sevenfold. These results indicate that the sequence immediately downstream of the GRR, rather than the GRR itself, largely determines the eciency with which p52 and p50 are generated. This downstream region, however, does not contain obligate regulatory elements, as it can be replaced with foreign sequences (Betts and Nabel, 1996; Lin et al., 1998) . We suspect that the intrinsic folding properties of the natural or foreign downstream sequences may determine the ratio of the p52/p100 products produced.
Materials and methods

Expression vectors
Full-length human p100 and p105 cDNAs were subcloned (Beraud et al., 1994) into the pcDNA3.1(+) expression vector (Invitrogen, San Diego, CA, USA); these plasmids were termed pcDN100 and pcDN105, respectively. The GRR deletion mutant of p100 (p100/DGRR) was constructed by polymerase chain reaction (PCR) ampli®cation of the p100 cDNA excluding amino acids 346 ± 377. The GRR translocation mutant of p100 [p100/DGRR:GRR(292 ± 323)] was constructed by reinserting the PCR-ampli®ed GRR into the GRR deletion mutant at an upstream restriction site, thus repositioning the GRR to follow amino acid 291 rather than amino acid 346. The p100/p105 chimeras were constructed as follows. In the 2-1-1 chimera, amino acid residue 350 of p100 was fused to residue 375 of p105 at a newly created XhoI restriction site. The nomenclature was selected based on the origin of the speci®c fragments of DNA included:`1' for nfkb1 (p105/p50) and`2' for nfkb2 (p100/p52). The three numbers thus respectively describe the origin of the 5' fragment (from the N-terminus to the GRR), the GRR, and the 3' fragment (from the GRR to the carboxy terminus). The 2-2-1 chimera was created by joining residue 374 of p100 to residue 398 of p105. In chimera 1-2-2, residue 374 of p105 was fused to residue 351 of p100, at a newly created BglII restriction site. In the 1-1-2 chimera, residue 399 of p105 was fused to residue 375 of p105 in a similar manner. These fragments were then ligated into the pcDNA3.1(+) vector to yield the ®nal chimeric expression vectors, which are schematically depicted in Figure 6a . A series of nested Cterminal deletion mutants of p100 was generated as follows. PCR was used to amplify the N-terminal region of p100 to the indicated C-terminal amino acid. These fragments were then introduced into the pcDNA3.1(+) vector as a HindIII± XbaI fragment. An additional EcoRI restriction site was designed as part of the ampli®cation product to allow the selective inclusion or exclusion of a stop codon following the indicated amino acid for in vitro translation studies. S protein-labeling mix; Dupont NEN, Boston, MA, USA) was then added to each well for 30 min to 2 h at 378C. The cells were then washed and resuspended in complete medium additionally supplemented with 12.5 mg/ml cycloheximide to inhibit de novo protein synthesis. At speci®c chase timepoints
Synchronized in vitro translations
In the synchronized translation experiments, 75 mM aurintricarboxylic acid (Sigma) was added to the reaction mixture 3 min after the initiation of in vitro translation. This agent blocks further initiation of translation but not ongoing translation by bound ribosomes. Samples of the mixture were then harvested at speci®ed timepoints and quenched in a pre-chilled Stop solution (20 mM Tris-HCl, pH 7.5, 5 mM MgCl 2 , 1 mM ATP, 2 mM puromycin). Immunoprecipitations were performed with a rabbit polyclonal antiserum speci®c for the N-terminus of p100. Immunoprecipitates were washed and analysed by sodium dodecyl sulfate ± polyacrylamide gel electrophoresis (SDS ± PAGE) and¯uorography.
In vitro transcription/translation
The p100 C-terminal truncation expression vectors were linearized by digestion with EcoRI (product lacks a stop codon in the reading frame) or XbaI (product contains a stop codon in the reading frame). The linearized constructs were then transcribed in vitro with T7 RNA polymerase according to the manufacturer's instructions (Boehringer Mannheim, Indianapolis, IN, USA). The resultant mRNA was translated in rabbit reticulocyte lysate (Promega, Madison, WI, USA) in the presence of 0.4 mCi/ml [ 35 S]methionine for 1 h. The lysate was immunoprecipitated with protein A-Sepharose beads and a rabbit polyclonal antiserum speci®c for the N-terminus of p100.
Abbreviations RHD, Rel homology domain; GRR, glycine-rich region; NLS, nuclear localization sequence.
